Medscape December 3, 2021
Data released by hospitals about their prices have yielded clues about how consumers might someday look to manage their medical costs. But so far, teasing out useful information has been an exercise that frustrates even savvy researchers.
Take the experience of pharmaceutical analyst Aharon (Ronny) Gal, PhD, who, working through his Moto Bioadvisors business, examined hospital price-posting on behalf of the Community Oncology Alliance (COA). Moto’s report was submitted by COA to the Centers for Medicare & Medicaid Services (CMS) as part of a comment favoring tougher penalties for hospitals that fail to meet federal transparency standards, as reported by Medscape Medical News.
In a report submitted by COA to CMS about the 2022 Medicare hospital outpatient rule, Gal and...